This week on MIP: UPC transparency blow, Spruson & Ferguson loses managing director
Managing IP is part of the Delinian Group, Delinian Limited, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

This week on MIP: UPC transparency blow, Spruson & Ferguson loses managing director

Documents locked with padlock and chains.

We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP

Exclusive: Spruson & Ferguson loses Asia managing director

Kristian Robinson, managing director of Spruson & Ferguson’s Asia practice, has resigned from his position, he confirmed to Managing IP on Wednesday, February 14.

Robinson, who works from the firm’s regional headquarters in Singapore, will depart during the financial year 2025, which runs from July 1 2024 to June 31 2025.

A formal departure date has yet to be finalised.

To read the full article click here.

UPC Court of Appeal issues fresh transparency blow

The Court of Appeal of the Unified Patent Court has ruled that members of the public cannot request access to court documents without first appointing a professional representative, in a decision likely to inflame ongoing transparency debates.

In a judgment handed down on Thursday, February 8, the court said it interpreted the Rules of Procedure as clarifying that the requirement for a “party” to be represented also extends to members of the public when applying for access to documents.

To read the full article click here.

Fish & Richardson launches life sciences industry team

US intellectual property firm Fish & Richardson has launched a life sciences industry team, Managing IP revealed on February 12.

The firm appointed litigator Martina Hufnal and patent prosecutor Todd Garcia – both of whom were already at the firm – to chair the team. The group will represent pharma, medical device, medtech, and biotech businesses, in addition to academic and research institutions.

To read the full article click here.

Other articles published on Managing IP this week include:

Weekly take: EU’s NGT plant patent ban is a ‘fatal signal’

In-house counsel share trademark registration worries

UPC monitoring: How EIP Amar keeps track of the latest rulings

Lawyers anticipate ‘heightened obligation’ to probe clients over AI use

Lawyers cautiously optimistic over India’s AI stance

The IP Lounge: SEPs update, IP hiring trends

Sixty cases and counting: why Bardehle’s UPC bet is paying off

Introducing Managing IP+'s Talent Tracker

Five minutes with… Mitch Boult, Adams and Reese

Texas trends: the state of play at patent hotspot

Managing IP EMEA Awards 2024: shortlists revealed

Elsewhere in IP

Man City fightback

The owners of UK football club Manchester City have this week asked the England and Wales High Court to dismiss a trademark infringement claim filed by fashion brand Superdry.

In December, Superdry claimed the club’s training kits, which use the words "Super 'Dry' Asahi 0.0%", infringed its trademark.

Advantage OpenAI

The US District Court for the Northern District of California has dismissed some of the claims in a copyright infringement filed by a group of authors against OpenAI.

The plaintiffs, including comedian Sarah Silverman, had accused OpenAI of illegally scraping their work without consent to train its large language models.

But in an order published on Monday, February 12, Judge Araceli Martínez-Olguí found that the plaintiffs had failed to explain what OpenAI’s outputs entailed or that any particular output was substantially similar to their works.

A claim of unfair business practices will proceed.

COVID impasse

The World Trade Organization (WTO) has failed to reach an agreement to waive intellectual property rights on COVID-19 tests and treatments for poorer countries.

Members of the TRIPS council said on Tuesday, February 13 that it had failed to reach a consensus despite the “considerable efforts” of members.

Avanci advancement

General Motors is the latest company to join the Avanci 5G vehicle programme, Avanci announced on Tuesday, February 13.

Under the agreement, 5G-connected vehicles from General Motors brands will be licensed to use the 5G, 4G, 3G, and 2G standard-essential patents belonging to participating programme members.

Launched in August 2023, Avanci's programme covers more than a dozen auto brands and has over 60 licensors.

Fake medicines seizures

Europol, in collaboration with the EUIPO, the European Anti-Fraud Office, and others has targeted the sale of counterfeit medicine under a programme called Operation Shield.

During the seven-month operation, 1,284 individuals were charged. There were also seizures of fake and illicit medicine worth more than €64 million ($69 million).

That's it for today, see you again next week.

more from across site and ros bottom lb

More from across our site

High-earning businesses place most value on the depth of the external legal teams advising them, according to a survey of nearly 29,000 in-house counsel
Kilpatrick Townsend was recognised as Americas firm of the year, while patent powerhouse James Haley won a lifetime achievement award
Partners at Foley Hoag and Kilburn & Strode explore how US and UK courts have addressed questions of AI and inventorship
In-house lawyers have considerable influence over law firms’ actions, so they must use that power to push their external advisers to adopt sustainable practices
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Counsel say they’re advising clients to keep a close eye on confidentiality agreements after the FTC voted to ban non-competes
Data from Managing IP+’s Talent Tracker shows US firms making major swoops for IP teams, while South Korea has also been a buoyant market
The finalists for the 13th annual awards have been announced
Counsel reveal how a proposal to create separate briefings for discretionary denials at the USPTO could affect their PTAB strategies
The UK Supreme Court rejected the firm’s appeal against an earlier ruling because it did not raise an arguable point of law
Gift this article